Alternatives to BrainSightAI

A cloud platform that is accessible from anywhere, infinitely scalable, and powered by AI offers collaborative features while adhering to the strictest security and compliance standards. This user-friendly software, designed by specialists in neuroimaging and data science, addresses the specific and complex requirements of the neuroscience field. Customized to suit your particular needs, it supports a wide range of activities, including research, clinical trials, point-of-care applications, algorithm development, and the utilization of brain-related data. The platform facilitates global data aggregation and consolidates imaging studies into a single cloud environment. It provides an efficient, comprehensive management solution for clinical, real-world data, and medical imaging information. Users receive tailored, expert assistance throughout their studies to ensure successful outcomes. Additionally, it features centralized reading capabilities and the option to compare quantitative results against a normative database. The platform also guarantees high-quality, shareable reporting and data export options to streamline the submission approval process, making it an invaluable tool for neuroscience professionals. Furthermore, its innovative design enhances collaboration among researchers and clinicians, fostering a community dedicated to advancing the field.

IntelliSpace Portal 9.0 is an innovative visualization platform encompassing over 70 clinical applications, providing a cohesive solution that enhances speed and efficiency while boosting diagnostic confidence, particularly in the analysis and monitoring of complex cases. As the global population ages, the prevalence of neurodegenerative diseases continues to escalate, necessitating long-term monitoring for patients with neurological disorders, which can often exhibit subtle brain changes that are difficult to identify. To address these challenges, IntelliSpace Portal 9.0 introduces several new and improved neuro applications, including NeuroQuant®¹, LoBi, and CT Brain Perfusion, all designed for swift, objective, and consistent image assessment. Additionally, with a growing focus on pulmonary health, this platform equips you with a comprehensive suite of tools to seamlessly manage pulmonary disease from initial detection through to ongoing follow-up, ultimately aiming to improve patient outcomes. This integration of neuro and pulmonary features positions IntelliSpace Portal 9.0 as a vital resource in modern medical imaging and diagnostics.

Brainlab's Elements Contrast Clearance Analysis is an MRI-based technique aimed at distinguishing areas of contrast clearance and accumulation within brain tumor imaging datasets. This advanced high-resolution analysis enhances the understanding required for ongoing evaluations and decision-making across various clinical fields, including radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The methodology entails capturing two standard 3D T1-weighted MRIs; the first scan is taken around 5 minutes after administering a standard dose of contrast agent, while the second scan occurs 60 to 105 minutes later. By subtracting the initial series from the subsequent one, volumetric maps are created that clearly identify zones of contrast clearance (shown in blue) against those of contrast accumulation (illustrated in red). These findings empower clinicians to better evaluate the effects of radiation treatment in contrast to potential tumor regrowth, allowing for more educated decisions regarding both initial and subsequent treatment plans. As a result, this analysis not only aids in clinical assessments but also enhances the overall management of patient care in complex cases.

Altris AI is an advanced, cloud-based clinical decision support system powered by artificial intelligence, specifically tailored to aid eye care professionals in interpreting OCT scans and making informed decisions. The platform streamlines the identification of pathological OCT scans while recognizing over 70 retina-related pathologies and biomarkers, which include some that are quite uncommon. Features of the system encompass severity detection, analysis of retina layer thickness, layer segmentation, and both automatic and manual measurement capabilities. It is designed to work seamlessly with all OCT devices and accommodates various data formats like DICOM, JPEG, and PNG. Furthermore, Altris AI has received FDA clearance, CE certification, and is compliant with GDPR and HIPAA regulations, thereby upholding rigorous standards for data security and patient confidentiality. By integrating this innovative tool into their practices, eye care professionals can significantly enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases over time. As a result, the adoption of Altris AI not only streamlines workflows but also elevates the overall quality of patient care in eye health.

Cardiovascular diseases result in more than 20 million fatalities globally each year, many of which could be avoided through timely detection. Unfortunately, the healthcare sector is often stretched thin, hindered by the limitations of human analysis capabilities. This is where AIATELLA makes a significant impact. Our innovative AI-driven image analysis technology revolutionizes cardiovascular diagnostics. By automating the intricate measurements of blood vessels and leveraging historical data, we substantially reduce the time, expenses, and required expertise, thereby enhancing the potential for vital imaging procedures. AIATELLA's approach not only accelerates the diagnostic process but also boosts the precision and reliability of results, providing critical measurements and disease progression insights in mere seconds rather than hours. As a result of this increased efficiency and accuracy in analyses, healthcare providers can dedicate more time to patient care, ultimately paving the way for effective preventative strategies and personalized treatment options for everyone. This shift could redefine how we approach cardiovascular health on a global scale.

Apollo Medical Imaging Technology is a pioneering software company focused on enhancing medical imaging through innovative image processing solutions tailored for both clinical and research purposes. Their leading product, MIStar, stands out as a cost-effective and user-friendly software suite that encompasses a wide range of advanced features and versatile cross-modality solutions, catering to the needs of clinicians and original equipment manufacturers alike. MIStar efficiently accommodates several imaging modalities, including CT, MR, NM, and PET, and boasts specialized modules such as CT Perfusion for stroke and various tumors, DSC-MRI for stroke analysis, DCE-MRI for tumor assessments, as well as DWI & ADC, and DTI Fiber Tractography. Additionally, it offers NM Renogram Analysis and Image Fusion capabilities, making it a comprehensive tool in medical imaging. The software also ensures seamless data management and image input via DICOM networking, complemented by an intuitive clinical database that facilitates easy anonymization and archiving of sensitive patient data. This combination of features positions MIStar as a crucial asset in modern medical imaging practices.

Us2.ai is revolutionizing the battle against heart disease by utilizing AI-driven ultrasound software that ensures heart health can be accessible to everyone. This innovative platform provides 45 automated echo parameters, such as strain analysis, and enables real-time interpretation of 2D and Doppler images. It seamlessly integrates with any ultrasound machine, producing zero-click, comprehensive reports that maintain high accuracy and can be easily compared with expert evaluations. The AI echo copilot from Us2.ai autonomously analyzes all heart chambers through both 2D and Doppler perspectives, incorporating global reference guidelines into detailed, real-time reports. Recently, the software obtained FDA clearance for Us2.v2, which also boasts 45 automated echo parameters, including strain analysis, representing a remarkable advancement in healthcare technology. Ultimately, Us2.ai aims to democratize echocardiography, ensuring that ultrasound technology is available to individuals regardless of their location or circumstances, thereby promoting better heart health for all. This commitment to accessibility and innovation positions Us2.ai at the forefront of the medical technology landscape.

Our innovative AI solutions are crafted to enhance the capabilities of healthcare professionals at critical stages of the medical process. Whether it's during preventive screenings, early diagnosis, emergency interventions, managing institutional disease outbreaks, or ensuring treatment compliance, we facilitate a smooth optimization of workflows throughout the entire care spectrum. By partnering with esteemed healthcare authorities and leveraging vast amounts of data to inform our algorithms, we ensure that our AI meets the highest global regulatory requirements. Supported by extensive research in data science, our offerings are designed to predict healthcare needs, especially in challenging situations. Our AI solutions are primed for immediate use, adaptable to various settings and situations as necessary. They seamlessly integrate with your existing technology framework and can be customized to work with your preferred devices. We provide straightforward deployment and scaling options while guaranteeing top-tier data security that complies with industry standards. Additionally, our dedicated team is committed to guiding you through every phase of your AI implementation journey, ensuring you feel confident and supported. With our solutions, you can transform your healthcare delivery and improve patient outcomes significantly.

Enhance your examination capabilities from any location and boost patient outcomes with intuitive, real-time imaging that is both economical and highly portable. Introducing the groundbreaking 3rd generation portable ultrasound, which is now 30% smaller and lighter than its predecessors. The Clarius HD3 offers unparalleled portable ultrasound technology tailored for your specific specialty, featuring a user-friendly app driven by artificial intelligence and seamlessly integrated with cloud connectivity. With the Clarius HD3, you can expect crisp and clear imaging that makes it simple to pinpoint anatomy, accurately diagnose conditions, and guide procedures in real-time right at the patient's side. This innovative device is equipped with artificial intelligence, 192 piezoelectric elements, and an impressive eight beamformers, which together provide the superior performance typically associated with cart-based systems, all while maintaining the lightweight feel of a conventional probe. As we move towards a future where smart devices operate without ports, the Clarius HD3 incorporates cutting-edge antenna technology designed for the most dependable direct WiFi connection to your mobile iOS or Android devices, eliminating the need for ports or cables altogether, thus ensuring maximum convenience. This advancement represents a significant leap forward in diagnostic imaging technology.

HeartFlow offers a groundbreaking, non-invasive cardiac test that delivers detailed visualizations of individual coronary arteries, allowing doctors to develop more tailored treatment strategies for their patients. The process begins when a patient has a standard coronary computed tomography scan performed at a medical facility. Following this scan, the CT images are securely sent to our cloud-based system. Utilizing cutting-edge algorithms powered by artificial intelligence, we create a customized digital representation of the patient's coronary arteries. Our skilled analysts then review this model, making necessary adjustments to ensure accuracy. After finalizing the patient-specific model, the HeartFlow pathway employs physiological principles and computational fluid dynamics to analyze blood flow and compute FFRCT values throughout the model. We adhere to strict and well-established protocols throughout this entire process, ensuring uniform processing for every individual patient, which ultimately enhances the quality of care provided. This innovative approach not only improves diagnostic precision but also empowers healthcare providers to make informed decisions for optimal patient outcomes.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

Axial3D is committed to enhancing personalized healthcare by revolutionizing the industry with its innovative 3D medical imaging and tailored patient solutions, thereby making individualized surgical care both routine and scalable. Their proprietary AI-driven platform, which operates in the cloud, enables medical device manufacturers, imaging specialists, and healthcare facilities to utilize rich data for creating precise 3D models that facilitate better surgical planning, lead to improved patient outcomes, and streamline workflows. Among the offerings are 3D visualizations, mesh files, print-ready files, and actual 3D printed models, all crafted to seamlessly fit into current medical practices. By transforming intricate DICOM images into accurate, actionable 3D representations, the company significantly enhances efficiency, speed, and scalability in the development of patient-specific devices. The cloud-based platform uniquely equips surgeons with a detailed perspective of their patient’s anatomy before surgery, thereby improving the accuracy and precision of surgical planning far beyond what traditional 2D imaging can provide. This advancement not only benefits individual patients but also paves the way for broader applications in the medical field.

Diagnosis refers to the process of determining what disease or condition is causing a person's symptoms and test results. DDxHub – Differential diagnosis Hub is a system that distinguishes a specific disease or condition from others with similar symptoms and lab results. DDxHub is a concentrator which holds a lot disease descriptions. DDxHub can be useful when you are trying to find the right diagnosis by comparing multiple diagnoses. You can upload your own disease definition to DDxHub repository, and then share it with other DDxHub users worldwide. You will receive disorder descriptions from other DDxHub users in return. Join thousands of healthcare professionals and patients who already love DDxHub’s differential diagnosis, sync, disorders description sharing solution. DDxHub can be used by medical students in clinical therapeutics as an educational resource.

The Montreal Cognitive Assessment (MoCA) is a concise, 30-item evaluation designed for healthcare professionals to identify cognitive deficits at an early stage, facilitating quicker diagnoses and enhanced patient management. This tool enables both healthcare providers and researchers to recognize cognitive challenges associated with various conditions, including Alzheimer's disease, Parkinson's disease, and several others such as frontotemporal dementia and brain tumors. MoCA is frequently utilized by a diverse range of practitioners, including nurses, primary care doctors, specialists, occupational therapists, and psychologists, among others. It efficiently evaluates critical cognitive functions such as short-term memory, visuospatial skills, executive functioning, attention, and language abilities, as well as orientation to time and place. The versatility of MoCA makes it an essential component of cognitive health assessments across various settings.

Developed by healthcare professionals for their peers, this technology aims to significantly enhance the quality of life for patients. Our AI-driven platform emphasizes speed, scalability, and security while offering the flexibility and customization that each hospital requires. It serves as a dependable long-term resolution. With RapidAI's stroke portfolio, you can expedite triage and transfer decisions with greater precision. Additionally, it facilitates the swift identification, monitoring, and proactive management of aneurysms. RapidAI's comprehensive suite of products for pulmonary embolism care enables quick detection of suspected PE cases. The AI-enhanced clinical decision support (CDS) software accelerates the decision-making process for physicians; however, it is crucial to recognize that not all AI solutions are equal. Only those CDS tools that possess clinical expertise can accurately identify, locate, characterize, and quantify suspected conditions. This advanced level of precision in AI-powered CDS modules contributes to improved triage and transfer decisions, ultimately leading to enhanced diagnostic accuracy and more efficient vascular care. By integrating these cutting-edge tools, healthcare providers can significantly elevate patient outcomes and operational efficiency.

Zebra's Imaging Analytics Engine processes imaging scans from multiple modalities and conducts automatic analyses of various clinical findings, ensuring efficiency and seamless integration with the radiology workflow. Healthcare providers rely on Zebra-Med to notify them about patients who are at elevated risk for cardiovascular, pulmonary, skeletal, and other health issues. This system enhances preventative care initiatives, supports accurate risk adjustments, and aids in meeting quality benchmarks like MACRA. By utilizing Zebra-Med, healthcare professionals can concentrate their efforts on the most vulnerable patients at critical moments, ultimately leading to reduced expenses and enhanced patient care outcomes. Consequently, this innovative approach not only improves the quality of care provided but also optimizes resource allocation across the healthcare system.

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

Engage with a medical-focused generative AI that not only elucidates its responses but also cites relevant references, refreshes its medical knowledge on a daily basis, and allows users to personalize and select knowledge bases. This AI comes equipped with a pre-loaded database and has been trained using over 2,300 reference datasets put together by experts in the medical field, encompassing a wide array of terminologies, medical research, clinical trials, patents, population health insights, costs, as well as public and regulatory information. It indexes numerous sources of medical research and data, ensuring a comprehensive understanding of the available information. The system is designed to receive daily updates on the latest medical findings, clinical trial results, and evolving terminologies, making it capable of processing vast quantities of documents, potentially reaching into the millions or billions. Moreover, the cluster can be scaled according to specific requirements. As a type of conversational AI, a medical chatbot employs natural language processing (NLP) technologies to communicate with users, delivering valuable medical information, guidance, or assistance. These chatbots serve various functions, including addressing general inquiries regarding diseases, health concerns, and available treatment options, thus enhancing the accessibility of medical knowledge for users everywhere.

Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.

mPower Clinical Analytics, created by Nuance and seamlessly integrated with Microsoft’s Azure platform, is a sophisticated analytics tool aimed at optimizing radiology workflows. This solution empowers healthcare providers to derive meaningful insights from unstructured clinical data, ultimately leading to better decision-making and enhanced operational efficiency. Utilizing artificial intelligence and machine learning, mPower Clinical Analytics plays a crucial role in recognizing trends, forecasting results, and refining processes in radiology departments. As a result, it not only boosts productivity but also contributes to improved patient care outcomes.

The Butterfly iQ+ is engineered to simplify the ultrasound experience. By connecting it to either our iOS or Android application, users can effortlessly select from 22 presets within seconds with just a finger swipe, enabling immediate scanning capabilities. This device is driven by our cutting-edge Ultrasound-on-Chip™, which expands the boundaries of ultrasound technology. With patented on-chip digital micro-beamforming, it achieves frame rates that are 15% faster and pulse repetition frequencies that are 60% quicker. Furthermore, its 1.75D array beamforming significantly reduces elevation beamwidth by 85%. Featuring an innovative low-noise, low-power semiconductor process paired with optimized electronics and a power-efficient FPGA, the device is designed for efficiency. Simply plug it into your mobile device, start scanning right away, and enhance your capabilities with Butterfly Education. Experience the precision you need with vivid color representation that accurately illustrates hemodynamic flow. The iQ+ is the world's only device utilizing Ultrasound-on-Chip™ technology, enabling users to effectively identify A lines, B lines, and pleural irregularities, resulting in quicker and clearer diagnostic insights. This remarkable tool not only enhances scanning efficiency but also elevates the overall quality of patient care.

Deeplink Medical has centered its offerings around the MIRIO platform, which is designed to cater to the varying use cases and requirements of stakeholders engaged in medical imaging within oncology, both in clinical settings and routine practice. Our services encompass three distinct yet interconnected solutions: MIRIO, which tracks evaluations of solid tumors and monitors the therapeutic responses of oncology patients; a streamlined patient pathway that bridges hospital facilities with private medical practices; and an Imaging CRO dedicated to the oversight of imaging data in oncological clinical trials. The development of our innovative solutions is bolstered by a scientific board, ensuring a robust foundation for our offerings. Additionally, our collaborative workflow platform organizes imaging data and radiological assessments for patients with solid tumors, facilitating real-time data structuration in accordance with RECIST 1.1 and iRECIST guidelines right from the moment the data is generated at investigation sites. This enables immediate evaluation of treatment responses based on established international standards, ultimately enhancing the quality and efficiency of patient care in oncology. By integrating these services, we aim to provide a comprehensive approach that supports healthcare professionals in delivering optimal treatment outcomes.

RedBrick AI serves as a rapidly collaborative platform for annotating medical data, specifically designed to assist healthcare AI teams in creating high-quality training datasets across various types of radiological imagery, including CT, MRI, X-ray, Ultrasound, Fluoroscopy, and additional standard imaging techniques. The platform is adept at managing intricate tasks such as multi-series annotation and extensive DICOM studies, thanks to its native compatibility with medical data formats including DICOM and NIfTI. Furthermore, it boasts cutting-edge, user-friendly 2D and 3D web-based annotation tools, complemented by a PACS-like viewer. RedBrick AI supports a wide array of annotation use cases, including instance and semantic segmentation, landmark identification, classification, and ROI measurements, thereby enhancing the speed of annotation processes by as much as 60%. This significant improvement in efficiency can empower healthcare professionals to focus more on patient care rather than on time-consuming data preparation tasks.

Pulse is a cloud-based solution designed for echocardiography labs aiming to enhance efficiency and patient outcomes. This platform facilitates reporting, storage, and analysis of echocardiograms, ensuring that you can access patient information whenever and wherever it's needed. Physicians benefit from the ability to review studies and finalize reports from virtually any location, making it an essential tool for contemporary echocardiography practices. With a user-friendly and robust reporting interface conveniently located alongside images and measurements, Pulse empowers users to navigate their tasks seamlessly. Its AI-driven features allow for fully automated measurements of GLS, LVEF, LVEDV, and LVESV, eliminating the need for manual input. Furthermore, the platform minimizes security risks while maximizing the advantages associated with cloud-native technology. Reports can be sent directly to your electronic health record (EHR) via HL7, effectively streamlining clinical workflows. You can easily store new studies right from the cart or retrieve existing studies from an external PACS. Moreover, integrated support for DICOM-TLS simplifies the management of secure data access, sparing users from the complexities of VPN setups. Overall, Pulse is revolutionizing the way echocardiography labs operate by combining technology with clinical expertise.

Brainlab's Elements Spine Stereotactic Radiosurgery (SRS) represents a cutting-edge software solution aimed at refining the management of spinal metastases. This innovative workflow features automation at each phase, encompassing anatomical mapping, curvature adjustments, and target identification, which guarantees precision and uniformity down to submillimetric levels. A distinctive algorithm addresses variations in spinal curvature, thereby improving the accuracy of image fusion. The software employs automatic segmentation of spinal anatomy through a patented synthetic tissue model that effectively identifies and labels different spine levels for accurate dose calculations. Tools for outlining spinal tumors are included for Gross Tumor Volume (GTV) contouring, along with automatic suggestions for the Clinical Target Volume (CTV) and a cropped spinal canal object in alignment with International Spine Consortium Guidelines. Furthermore, the integration of AI-driven contouring solutions allows for the swift and dependable delineation of over 200 structures, including lymph nodes. This advancement not only streamlines the treatment process but also enhances overall patient outcomes in spinal cancer management.

Aidoc creates cutting-edge decision support software powered by AI specifically designed for the healthcare sector. This innovative technology processes medical imaging to deliver one of the most thorough solutions for identifying acute abnormalities throughout the body, enabling radiologists to prioritize critical cases and accelerate patient treatment. By equipping radiologists with tools to swiftly detect urgent medical conditions, it effectively minimizes the overall time taken to generate reports, seamlessly integrating into their workflow. The 510(k) triage and notification software is tailored for evaluating non-enhanced head CT images, alerting users to suspected positive findings such as Intracranial Hemorrhage (ICH). Additionally, the software is suitable for analyzing Head CTA images, where it identifies and communicates the presence of Brain Aneurysms (BA), as well as for Chest X-Ray images, where it flags the occurrence of Pneumothorax (Ptx). This multifaceted approach not only enhances diagnostic accuracy but also significantly improves patient outcomes by ensuring timely interventions.

NovaPACS EI represents a cutting-edge PACS solution that integrates enterprise imaging, revolutionizing how healthcare facilities manage, display, and disseminate medical images, multimedia content, and patient data. This system effectively supports various medical disciplines including radiology, cardiology, pathology, and mammography, while offering tools for encounter-based imaging across the entire healthcare system. By breaking down traditional silos of patient information, it empowers electronic medical records (EMRs) with a patient-centric Universal Viewer, ensuring that healthcare providers have access to crucial information precisely when they need it, which aids in making more accurate diagnoses and enhances value-based care delivery. Additionally, it fosters improved doctor-patient interactions through engaging storyboards, thereby enriching the overall patient experience. The system also facilitates collaboration among multiple specialties and departments, enhancing operational efficiency and cost control. NovaPACS EI is designed to be scalable, accommodating the needs of large hospitals as well as critical access facilities, effectively managing the care of patients with chronic or complex conditions throughout their healthcare journey. Ultimately, this innovative approach not only streamlines workflows but also optimizes patient outcomes.

Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.

For more than ten years, TraumaCad software has provided orthopedic surgeons with the ability to visualize their anticipated outcomes before beginning procedures, thereby facilitating seamless surgical processes from initiation to completion. This software boasts a comprehensive digital library of templates and encompasses a wide array of measurement tools suitable for every aspect of the orthopedic field, including Total Hip Replacement (THR), Total Knee Replacement (TKR), trauma cases, pediatric procedures, deformity correction, foot and ankle surgeries, spinal interventions, and upper limb treatments. Users can benefit from a range of automated features, such as image recognition for precise calibration and Auto planning for Total Hip and Knee Replacement procedures, which streamline the planning process. Additionally, regular automatic updates guarantee that you are using the most current software version and template resources available. Pre-operative reports can be generated with ease, encapsulating patient images, implant details, measurements, and additional notes, ensuring that all relevant information is organized and accessible for review. This blend of functionality and innovation ultimately enhances the overall efficiency and effectiveness of surgical planning in orthopedic care.

CADU, a cloud-enabled AI solution created by Odin Vision, is designed to aid in identifying and characterizing dysplasia in individuals with Barrett’s oesophagus during gastroscopy. The system evaluates areas that visually resemble Barrett’s oesophagus and offers insights to help clinicians determine whether the tissue is dysplastic or non-dysplastic. By improving the decision-making process for endoscopists and expediting the examination of the oesophagus, CADU proves to be both time-efficient and cost-effective. Additionally, it functions on a platform that is vendor-neutral, facilitating its use with various endoscopic equipment. The system is CE marked and holds UKCA approval; however, it is not available for commercial sale in the United States. CADU has been adopted in clinical environments, including University College London Hospitals, aiming to enhance the detection of early oesophageal cancer, which can often be difficult to identify due to the subtle nature of initial lesions. Its implementation represents a significant advancement in the early diagnosis of this serious condition, highlighting the importance of technology in modern medicine.

Healthcare providers and pharmaceutical firms leverage RetinAI's software platform to effectively manage their data while benefiting from enhanced insights through automated AI analysis, thereby optimizing both clinical and research workflows. This unified data platform allows users to access and manage their information from any location at any time. It supports a variety of formats, including DICOM-compliant and proprietary types. By utilizing AI, data is harmonized, organized, aggregated, and analyzed on a large scale to uncover insights related to disease progression, treatment outcomes, and predictions of disease advancement. Additionally, the platform facilitates collaborative research within organizations by providing secure cloud-based access to data. It serves as a central hub for data, medical, and digital teams. Users can conduct AI-driven analysis on their OCT volumes, focusing on layer and fluid segmentation. Immediate evaluations can be performed to consolidate insights into a single platform. Collaborators can be swiftly invited to access and interact with datasets according to specified permission levels, fostering a more integrated research environment. This comprehensive approach not only streamlines data management but also enhances collaborative efforts across different teams and disciplines.

Founded in 2016, Infervision stands at the forefront of AI-driven medical technology, dedicated to enhancing multidisciplinary healthcare services and operations through innovative artificial intelligence solutions. Their advanced AI offerings are designed to assist healthcare professionals across a spectrum of tasks, including disease screening, diagnosis, intervention, treatment, patient management, and medical research. Among their array of solutions, InferRead CT Lung specializes in detecting lung nodules from chest CT scans, while InferRead DR Chest focuses on identifying chest abnormalities via X-ray imaging. Moreover, InferRead CT Coronary is tailored for recognizing coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is adept at triaging hemorrhages from brain CT scans. The company also provides InferRead CT Bone for spotting chest fractures in CT images and InferRead CT Pneumonia for diagnosing and managing pneumonia cases. Beyond these, their offerings extend to InferOperate, which facilitates 3D reconstruction for thoracic, liver, and urological surgical procedures, and InferCare, a tool designed for effective patient management and image follow-up. Additionally, InferScholar acts as an AI-enhanced resource for medical research, further solidifying Infervision's commitment to transforming healthcare through AI technology. This comprehensive suite of solutions positions Infervision as a pivotal player in the evolution of medical practices.

NeuroICH is an innovative AI tool designed to identify cerebral hemorrhages, marking a vital advancement in the management and treatment of stroke patients. Rapid evaluation and imaging analysis are crucial, as the saying goes, "time is brain," highlighting the urgency of timely intervention. This groundbreaking technology not only aims to save lives but also to reduce the long-term impacts of strokes, such as disabilities. Furthermore, it has recently received FDA approval as a Software as a Medical Device (SaMD), underscoring its reliability and effectiveness in clinical settings.

Brainlab's Elements Multiple Brain Metastases SRS represents a cutting-edge software solution aimed at optimizing the planning and execution of treatment for patients suffering from multiple brain metastases. This innovative workflow allows healthcare providers to target several metastases at once without subjecting the entire brain to radiation, thus significantly shortening the duration of treatment delivery. The procedure starts with pre-planning steps that are supported by automation, which includes tasks like image fusion, distortion correction, object outlining, and segmentation; all of which enhance both the speed and precision of the planning process. The software utilizes inverse-optimized dynamic conformal arc techniques, focusing on a single isocenter to achieve highly conformal dose distributions with sharp gradients, ensuring accurate target coverage while protecting surrounding healthy tissue. This method facilitates the rapid generation of consistent, high-quality radiosurgery plans within minutes, ultimately benefiting clinicians and patients alike by reducing treatment durations and enhancing overall outcomes. Moreover, the efficiency and effectiveness of this software can lead to improved patient satisfaction and a more streamlined clinical workflow.

The Bookend Healthcare AI Agent platform enhances administrative efficiency across all stages, from patient care to payment processing. By simplifying intricate prior authorization procedures, it relieves healthcare providers from labor-intensive tasks and minimizes expensive denials. Through automation, we enable an increase in operational efficiency, expedite revenue cycles, and significantly enhance patient outcomes. Our sophisticated agents evaluate patient information, interpret insurance policies, and compile essential details for precise and prompt submissions, which leads to elevated approval rates and quicker reimbursements. Additionally, our AI-driven platform transforms the healthcare landscape by streamlining the creation and implementation of tailored care plans. We assist healthcare providers in proactively recognizing evidence-based interventions that optimize patient outcomes while simultaneously lowering costs. Moreover, this platform equips clinicians with the tools to make informed decisions based on data, thereby raising the quality of care and boosting patient satisfaction levels, ultimately fostering a more effective healthcare system.

CaptureITPro is an all-encompassing software solution for medical imaging and reporting, created by AmbalSoft to streamline the processes of capturing, storing, and managing high-resolution medical visuals and videos. This software is compatible with a diverse array of medical instruments, which include endoscopes, laparoscopes, bronchoscopes, gastroscopes, colonoscopes, cystoscopes, arthroscopes, and surgical microscopes. Users can record images in several formats such as BMP, JPG, and DICOM, while video recordings are available in AVI and MPEG formats. CaptureITPro excels in high-definition video capture, accommodating resolutions up to 1080p at frame rates of 50/60fps, employing H.264 compression for optimal storage efficiency. Additionally, it boasts a Picture-in-Picture feature that allows multiple video sources to be viewed simultaneously, thereby improving the clarity and understanding of medical procedures. The software is fully compliant with DICOM standards, which facilitates seamless integration with Hospital Management Systems (HMS) and Picture Archiving and Communication Systems (PACS), and it is capable of supporting modalities like ultrasound for comprehensive medical imaging solutions. Furthermore, CaptureITPro's user-friendly interface enhances workflow efficiency by simplifying the management of complex imaging tasks.

Clinically AI is an advanced collection of AI-driven tools designed for behavioral health documentation, capable of swiftly producing comprehensive clinical notes that adhere to compliance standards, all while ensuring that clinicians retain control and oversight over the content. This platform is chart-aware, as it comprehends and references a patient’s treatment plan, interventions, objectives, and progress, thereby maintaining a cohesive “golden thread” that connects notes to the actual care being provided. It accommodates both ambient and dictation functionalities, allowing for the capture of sessions through live audio or input after the session has concluded, and is compatible with telehealth platforms such as Zoom, Google Meet, and Teams, as well as in-person interactions, and works seamlessly with any browser-based EHR by utilizing a Chrome extension or API integration. Clinically AI is equipped to manage both discrete and narrative data fields, efficiently populating dropdowns, checkboxes, and conditional logic, and has the remarkable ability to generate up to 50 tailored notes from a single group session while ensuring that each note retains a personal touch. Additionally, it provides real-time audit capabilities to proactively identify compliance issues and includes supervision tools to facilitate the review of the work completed by clinicians. With Clinically AI, healthcare professionals can enhance their documentation processes, ultimately improving the quality of patient care and streamlining administrative tasks.

We combine clinical and experimental data through machine learning techniques to explore human disease biology and promote the development of precision medicine. Our innovative Contingent AI™ technology comprehends the intricate relationships present in the data, yielding advanced insights. To combat data bias, we refine our machine learning models based on decisions made during the pre-processing and feature engineering phases. We utilize zebrafish, cellular, and various phenotypic animal models to test and confirm in silico predictions through in vivo experiments, along with genetic modifications conducted both in vitro and in vivo to enhance translation. By employing active learning and computer vision on validated models that focus on cardiac, central nervous system, and rare disorders, we swiftly integrate new data into our machine learning frameworks, allowing for continuous improvement and adaptation in our methodologies. This iterative process not only enhances the accuracy of our predictions but also enables us to stay at the forefront of research in precision medicine.

Transform your healthcare experience with the revolutionary Soliton® AI, which is powered by 30,000 evidence-based rules and advanced machine learning techniques. By automating various healthcare and care management functions, Soliton® equips you with the tools necessary to thrive in a value-based care environment, offering unmatched capabilities. It efficiently analyzes vast amounts of patient data in real-time, leading to enhancements in both clinical outcomes and financial performance, while also supporting a range of Alternative Payment Models (APMs). The solution boosts the effectiveness of telehealth by forecasting billable codes during patient interactions and predicting future healthcare costs through sophisticated risk stratification models. Furthermore, it provides timely clinical decision support to assist in managing intricate patient populations. Soliton® optimizes the patient journey, facilitating seamless transitions from acute to post-acute care through AI-driven care coordination. Moreover, it identifies care gaps, uncovers service and coding opportunities, and generates tailored patient assessments and personalized care plans, while also enabling the creation of custom cohorts for targeted interventions. As a result, Soliton® not only enhances operational efficiency but also elevates the overall quality of patient care.

Droidal transforms healthcare revenue cycle management (RCM) through intelligent AI agents that automate administrative tasks, reduce errors, and drive faster reimbursements. Built for hospitals, physician groups, hospices, dental networks, and ambulatory care centers, it simplifies billing and claims processes end-to-end. The platform’s AI mimics human users, ensuring accuracy and compliance while scaling to handle millions of transactions per month. Healthcare organizations using Droidal report up to 40% automation of operational processes, 50% cost savings, and 25% increases in net patient revenue. Its agentic design eliminates repetitive work, shortens payment cycles, and delivers a 30–250% annual ROI. Unlike traditional RCM vendors, Droidal works within your existing infrastructure — no system overhauls required. With built-in human fail-safes and real-time exception management, it ensures every claim and transaction meets compliance standards. Backed by advanced security and transparent documentation, Droidal gives healthcare providers a faster, smarter, and more reliable way to manage their financial operations.

Over the past twenty years, collaboration with innovative thinkers has enabled the identification, understanding, and reduction of errors from biopsy to data, resulting in significant advancements in tissue data mining tools, precision, workflow, and automation. Explore the realm of image analysis and tissue mining in both multi and highplexed images, where you can extract clinically significant patterns that provide insights into diseases, transforming your research tissue images into valuable knowledge. Discover the capabilities of CE-IVD APPs and workflows in image analysis, and redefine the approach to standardization through AI-powered pathology solutions that enhance diagnostic decision-making. The app center serves as your entry point to an extensive library filled with AI-driven applications, including those designed to adapt to your specific requirements. Additionally, you can peruse our collection of publications, guides, webinars, and posters to deepen your understanding of digital pathology and see how our software continually supports our clients in their research efforts. Embrace the future of pathology by leveraging these innovative tools and resources to elevate your work and contribute to advancing medical science.

Medical AI represents a groundbreaking technological advancement that effectively tackles chronic illnesses. This innovative solution is distinguished by its capabilities to forecast outcomes, recommend optimal subsequent actions, and deliver information in a user-friendly manner. DeLorean Medical AI enhances human decision-making, paving the way for a future where both machines and humans collaboratively achieve superior results. Our technology not only enhances health outcomes but is also the first AI system to receive biological validation through independent clinical evaluations. By improving the classification of patient demographics, assessing risk factors, and forecasting transitions in disease states, Medical AI plays a crucial role in the early detection and diagnosis of various health conditions. Additionally, it contributes to cost reductions within healthcare systems. With over ten clients already utilizing our solution, it has proven effective in generating savings and reducing costs through real-time analytics that identify at-risk populations and provide next-best-action suggestions grounded in statistical evidence. Furthermore, as the healthcare landscape continues to evolve, the integration of such advanced technologies will become increasingly vital in ensuring better patient care and resource management.

The expenses, intricacies, and lengthy timelines tied to traditional methods of evidence generation hinder the agile nature of research and the broader incorporation of genuine patient insights within treatment development and commercial processes. Our HyperStream serves as the largest real-time stream of patient experience data globally, documenting the genuine digital narratives of diseases as expressed by real patients on various online platforms. Pharos acts as a web-based tool for evidence generation and a research framework that leverages its combined data streaming and AI functionalities to effectively gather online patient experience data, allowing teams to swiftly uncover vital evidence when necessary. Thus far, the Pharos Suite has proven effective in generating valuable evidence and patient insights across a variety of therapeutic areas and medical conditions, demonstrating its versatility and impact on research practices. This innovative approach not only enhances the speed of evidence gathering but also enriches the understanding of patient experiences in real-time.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

Nudge AI is a powerful tool for mental health professionals that leverages AI to automate the creation of SOAP notes, making documentation faster and more accurate. By using natural language processing and machine learning, Nudge AI generates detailed, personalized notes from session interactions, significantly reducing the time clinicians spend on administrative tasks. This platform ensures that therapists meet regulatory standards while allowing them to devote more time to patient care. With seamless integrations and continuous real-time feedback, Nudge AI empowers mental health professionals to improve productivity and the quality of their services.